102 related articles for article (PubMed ID: 21692688)
1. Drug delivery embolization systems: a physician's perspective.
Nicolini A; Crespi S; Martinetti L
Expert Opin Drug Deliv; 2011 Aug; 8(8):1071-84. PubMed ID: 21692688
[TBL] [Abstract][Full Text] [Related]
2. Transarterial therapies for hepatocellular carcinoma.
Sangro B; D'Avola D; Iñarrairaegui M; Prieto J
Expert Opin Pharmacother; 2011 May; 12(7):1057-73. PubMed ID: 21470073
[TBL] [Abstract][Full Text] [Related]
3. Current concepts in transarterial chemoembolization of hepatocellular carcinoma.
Huppert P
Abdom Imaging; 2011 Dec; 36(6):677-83. PubMed ID: 21674193
[TBL] [Abstract][Full Text] [Related]
4. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
Meza-Junco J; Montano-Loza AJ; Liu DM; Sawyer MB; Bain VG; Ma M; Owen R
Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960
[TBL] [Abstract][Full Text] [Related]
5. Advances in regional chemotherapy of the liver.
Dudeck O; Ricke J
Expert Opin Drug Deliv; 2011 Aug; 8(8):1057-69. PubMed ID: 21506902
[TBL] [Abstract][Full Text] [Related]
6. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
[TBL] [Abstract][Full Text] [Related]
7. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.
Raoul JL; Sangro B; Forner A; Mazzaferro V; Piscaglia F; Bolondi L; Lencioni R
Cancer Treat Rev; 2011 May; 37(3):212-20. PubMed ID: 20724077
[TBL] [Abstract][Full Text] [Related]
8. DC Bead embolic drug-eluting bead: clinical application in the locoregional treatment of tumours.
Lewis AL; Holden RR
Expert Opin Drug Deliv; 2011 Feb; 8(2):153-69. PubMed ID: 21222553
[TBL] [Abstract][Full Text] [Related]
9. Superselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspective.
Takayasu K
Oncology; 2011; 81 Suppl 1():105-10. PubMed ID: 22212943
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional microbeads for drug delivery in TACE.
Bannerman D; Wan W
Expert Opin Drug Deliv; 2016 Sep; 13(9):1289-300. PubMed ID: 27223469
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspective.
Takayasu K
Oncology; 2013; 84 Suppl 1():28-33. PubMed ID: 23428855
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
Malagari K; Pomoni M; Kelekis A; Pomoni A; Dourakis S; Spyridopoulos T; Moschouris H; Emmanouil E; Rizos S; Kelekis D
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):541-51. PubMed ID: 19937027
[TBL] [Abstract][Full Text] [Related]
13. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
Seki A; Hori S
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins?
Biolato M; Marrone G; Racco S; Di Stasi C; Miele L; Gasbarrini G; Landolfi R; Grieco A
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):356-62. PubMed ID: 20496548
[TBL] [Abstract][Full Text] [Related]
15. Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications.
Vogl TJ; Naguib NN; Nour-Eldin NE; Rao P; Emami AH; Zangos S; Nabil M; Abdelkader A
Eur J Radiol; 2009 Dec; 72(3):505-16. PubMed ID: 18835117
[TBL] [Abstract][Full Text] [Related]
16. Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads.
Guiu B; Deschamps F; Aho S; Munck F; Dromain C; Boige V; Malka D; Leboulleux S; Ducreux M; Schlumberger M; Baudin E; de Baere T
J Hepatol; 2012 Mar; 56(3):609-17. PubMed ID: 22027582
[TBL] [Abstract][Full Text] [Related]
17. A review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proof.
Liu DM; Thakor AS; Baerlocher M; Alshammari MT; Lim H; Kos S; Kennedy AS; Wasan H
Future Oncol; 2015; 11(9):1421-8. PubMed ID: 25602287
[TBL] [Abstract][Full Text] [Related]
18. Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy.
Lencioni R
Crit Rev Oncol Hematol; 2012 Aug; 83(2):216-24. PubMed ID: 22142656
[TBL] [Abstract][Full Text] [Related]
19. Intra-arterial therapies for hepatocellular carcinoma: where do we stand?
Liapi E; Geschwind JF
Ann Surg Oncol; 2010 May; 17(5):1234-46. PubMed ID: 20405328
[TBL] [Abstract][Full Text] [Related]
20. Chemoembolization for hepatocellular carcinoma.
Lencioni R
Semin Oncol; 2012 Aug; 39(4):503-9. PubMed ID: 22846867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
